Under the mantle of the Minnesota Partnership for Biotechnology and Medical Genomics, the University of Minnesota and Mayo Clinic in June committed to a formal research relationship with the Karolinska Institute of Stockholm, Sweden.
Karolinska is the top-rated medical research university in Europe. The partnership aims to accelerate and build on the existing relationships among the three institutions.
Perhaps due to Minnesota’s Scandinavian heritage, the state’s research universities have more than 30 years of relationships, partnerships, exchanges, and joint projects with Karolinska that have resulted in publications, research grants, and discoveries aimed at improving the health of people worldwide.
At the start, research collaborations will focus on regenerative medicine, bio-omics (which includes genomics, proteomics, and metabolomics), and immunity—all emerging areas of biomedical science.
Other plans include establishing fellowships for promising young investigators, as they will become tomorrow’s global leaders in biomedical research, to support exchanges in targeted research areas.
